Total Payments
$9,073
2024 Payments
$65.13
Companies
70
Transactions
536
Medicare Patients
18,556
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$8,729 (96.2%)
Education$343.51 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,729 | 527 | 96.2% |
| Education | $343.51 | 9 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $762.70 | 51 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $741.66 | 50 | $0 (2023) |
| Amgen Inc. | $657.76 | 32 | $0 (2023) |
| Lilly USA, LLC | $649.78 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $595.33 | 36 | $0 (2023) |
| Genentech USA, Inc. | $477.78 | 36 | $0 (2023) |
| Janssen Biotech, Inc. | $441.90 | 27 | $0 (2023) |
| Eisai Inc. | $380.35 | 19 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $298.89 | 13 | $0 (2023) |
| PFIZER INC. | $296.12 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.13 | 4 | ABBVIE INC. ($31.28) |
| 2023 | $1,925 | 87 | Merck Sharp & Dohme LLC ($196.26) |
| 2022 | $1,067 | 56 | Novartis Pharmaceuticals Corporation ($172.71) |
| 2021 | $1,004 | 58 | Lilly USA, LLC ($140.99) |
| 2020 | $989.59 | 62 | Amgen Inc. ($121.67) |
| 2019 | $1,266 | 77 | Amgen Inc. ($274.74) |
| 2018 | $1,430 | 99 | Novartis Pharmaceuticals Corporation ($198.92) |
| 2017 | $1,326 | 93 | Genentech USA, Inc. ($273.82) |
All Payment Transactions
536 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: DESMOID TUMORS | ||||||
| 04/01/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Education | Cash or cash equivalent | $6.11 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 02/24/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Oncology | ||||||
| 11/15/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $26.77 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/15/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 11/08/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $23.07 | General |
| Category: Oncology | ||||||
| 10/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Oncology | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Oncology | ||||||
| 10/17/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Oncology | ||||||
| 10/11/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Oncology | ||||||
| 10/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Oncology | ||||||
| 09/14/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Hematology | ||||||
| 09/07/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Oncology | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $99.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,412 | 64,857 | $1.0M | $242,254 |
| 2022 | 50 | 4,197 | 81,070 | $2.2M | $640,719 |
| 2021 | 63 | 5,821 | 108,141 | $2.1M | $618,340 |
| 2020 | 74 | 6,126 | 130,840 | $2.6M | $792,460 |
Total Patients
18,556
Total Services
384,908
Medicare Billing
$2.3M
Procedure Codes
216
All Medicare Procedures & Services
216 procedure records from CMS Medicare Utilization — Page 9 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82105 | Alpha-fetoprotein (afp) level, serum | Office | 2020 | 11 | 12 | $720.00 | $199.88 | 27.8% |
| 86431 | Rheumatoid factor level | Office | 2020 | 33 | 34 | $680.00 | $191.35 | 28.1% |
| 86705 | Hepatitis b core antibody (igm) measurement | Office | 2020 | 13 | 15 | $600.00 | $174.63 | 29.1% |
| 86704 | Hepatitis b core antibody measurement | Office | 2020 | 12 | 14 | $574.00 | $167.02 | 29.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 44 | 1,620 | $1,620 | $155.26 | 9.6% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 14 | 18 | $558.00 | $150.75 | 27.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 30 | 83 | $498.00 | $124.18 | 24.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2020 | 14 | 1,335 | $1,335 | $118.25 | 8.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 50 | 174 | $348.00 | $104.93 | 30.2% |
| 84550 | Uric acid level, blood | Office | 2020 | 15 | 22 | $374.00 | $98.63 | 26.4% |
| 85044 | Red blood count, manual test | Office | 2020 | 22 | 23 | $368.00 | $93.84 | 25.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2020 | 13 | 14 | $168.00 | $72.02 | 42.9% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2020 | 25 | 888 | $1,776 | $59.94 | 3.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 16 | 31 | $186.00 | $58.16 | 31.3% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2020 | 12 | 98 | $196.00 | $45.50 | 23.2% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2020 | 11 | 20 | $60.00 | $18.93 | 31.6% |
About Dr. Mark Robbins, MD
Dr. Mark Robbins, MD is a Hematology & Oncology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265442206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Robbins, MD has received a total of $9,073 in payments from pharmaceutical and medical device companies, with $65.13 received in 2024. These payments were reported across 536 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($8,729).
As a Medicare-enrolled provider, Robbins has provided services to 18,556 Medicare beneficiaries, totaling 384,908 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 216 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Cranston, RI
- Active Since 08/09/2006
- Last Updated 04/17/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1265442206
Products in Payments
- OPDIVO (Biological) $638.18
- KEYTRUDA (Biological) $501.10
- Lenvima (Drug) $271.03
- VERZENIO (Drug) $264.39
- CYRAMZA (Drug) $182.86
- Nplate (Biological) $176.56
- TECENTRIQ (Biological) $171.86
- XTANDI (Drug) $171.48
- JAKAFI (Drug) $157.14
- KISQALI (Drug) $154.16
- Enhertu (Drug) $147.56
- TASIGNA (Drug) $143.09
- IMBRUVICA (Drug) $130.26
- IBRANCE (Drug) $123.15
- ERLEADA (Drug) $120.28
- GILOTRIF (Drug) $112.83
- Cabometyx (Drug) $111.92
- BRUKINSA (Drug) $111.63
- ELIQUIS (Drug) $110.59
- Halaven (Drug) $109.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cranston
Dr. Plakyil Joseph, M.d, M.D
Hematology & Oncology — Payments: $23,585
Hematology & Oncology $23,585
Sundaresan Sambandam, M.d, M.D
Hematology & Oncology — Payments: $6,926
Hematology & Oncology $6,926
Ayesha Hassan, Md, MD
Hematology & Oncology — Payments: $376.35
Hematology & Oncology $376.35
Dr. Fatima Raza, M.d, M.D
Hematology & Oncology — Payments: $59.12
Hematology & Oncology $59.12